Jefferies Group LLC Cure Vac N.V. Put Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $3.15 Million - $4.77 Million	-64,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$56.91 - $127.53 $3.64 Million - $8.16 Million	64,000 New	64,000 $4.7 Million
Q2 2021 Aug 20, 2021	SELL	$56.91 - $127.53 $361 Million - $808 Million	-6,336,000 Reduced 99.0%	64,000 $4.7 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $364 Million - $816 Million	6,400,000 New	6,400,000 $4.7 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.